Curve Therapeutics is a venture-backed start-up company based on an innovative approach to targeting challenging disease targets developed by Prof Ali Tavassoli. The platform has been used to identify and report a number of cell-active, first in class inhibitors (including Miranda et al., 2013, J. Am. Chem. Soc. 135, 10418, Leitch et al., 2018, Chem. […]